ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,116.17
      0.32%
      US Tech 100
      17,297.60
      -0.07%
      Dow Jones
      38,386.09
      0.38%
      Brent Oil
      87.525
      0.27%
      Bitcoin
      61,259.38
      -4.04%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. Nevro Corp (NVRO)

      7. Nevro Corp (NVRO) News

      NVRO

      Nevro (NVRO)

      Nevro Corp
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:NVRO
      DateTimeSourceHeadlineSymbolCompany
      04/17/20248:30AMPR Newswire (US)Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024NYSE:NVRONevro Corp
      03/11/20244:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/11/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/11/20244:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/11/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/11/20244:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/06/20246:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/05/20244:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/05/20244:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/05/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/01/20245:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      03/01/20245:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      02/28/20244:10PMPR Newswire (US)Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral ScrewNYSE:NVRONevro Corp
      02/23/20245:08PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:NVRONevro Corp
      02/22/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:NVRONevro Corp
      02/22/20244:16PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:NVRONevro Corp
      02/21/20244:11PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
      02/21/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
      02/21/20244:06PMPR Newswire (US)Nevro Enters Into Cooperation Agreement With Engaged CapitalNYSE:NVRONevro Corp
      02/21/20244:05PMPR Newswire (US)Nevro Reports Fourth-Quarter and Full-Year 2023 Financial ResultsNYSE:NVRONevro Corp
      02/14/20243:47PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
      02/14/20243:38PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:NVRONevro Corp
      02/01/20244:30PMPR Newswire (US)Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic NeuropathyNYSE:NVRONevro Corp
      01/29/20244:30PMPR Newswire (US)Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024NYSE:NVRONevro Corp
      01/18/20244:15PMPR Newswire (US)Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic NeuropathyNYSE:NVRONevro Corp
      01/17/20244:15PMPR Newswire (US)Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual MeetingNYSE:NVRONevro Corp
      01/11/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNYSE:NVRONevro Corp
      01/10/20245:26PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NYSE:NVRONevro Corp
      01/09/20248:41AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:NVRONevro Corp
      01/09/20248:30AMPR Newswire (US)Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue ResultsNYSE:NVRONevro Corp
       Showing the most relevant articles for your search:NYSE:NVRO